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≥74 were categorised as severe, and remaining patients were
categorised as moderate. The median PLR, NLR, and non-HDL
cholesterol was calculated for each subgroup and were com-
pared using Mann–Whitney U-test.
Results: We have observed signiﬁcant correlation between PLR
and Gensini score (with Spearman's coefﬁcient of r = 0.727,
p < 0.05) as well as NLR and Gensini score (with Spearman's
coefﬁcient of r = 0.627, p < 0.05). However a correlation could
not be established between non-HDL cholesterol levels and Gen-
sini score (r = 0.49).
The median values of PLR and NLR were signiﬁcantly higher in
the severe group compared to the mild and moderate groups
with p < 0.01 for both PLR and NLR. Non-HDL cholesterol levels
were not found to be signiﬁcantly high or low among the sub-
groups.
Conclusion: We have established statistically signiﬁcant correla-
tion between PLR and NLR with severity of ACS. We recommend
the use of PLR and NLR as markers for severity of ACS. Non-HDL
cholesterol cannot be used as a marker for severity of ACS. Larger
studies are required for further evaluation of these markers as a
tool for assessing severity of ACS.
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Background and aims of the study: The presence of signiﬁcant
atherosclerotic coronary artery disease (CAD) in patients with
valvular heart disease is an important predictor of perioperative
mortality. The prevalence of CAD in patients undergoing valvular
heart surgery is 20–40% in developed countries. We aimed to see
CAD prevalence in our population undergoing valvular heart sur-
gery.
Methods: A total of 1500 patients (1000 males, 500 females; mean
age 52.5  12.9 years) who underwent coronary angiography before
valvular surgery between August 2003 and June 2012 was enrolled
retrospectively. Single valve and multiple valve involvement were
present in 43% and 56% of patients, respectively. Patients with
ischemic mitral regurgitation were excluded from the study. Sig-
niﬁcant CAD was deﬁned as the presence of >/=50% diameter
stenosis in any one of the coronary arteries. The presence of angina
pectoris and of risk factors (e.g. hypertension, smoking, diabetes
mellitus (DM), hyperlipidemia, family history of CAD) were sought
in all patients.
Results: Signiﬁcant CADwas present in 16% of patients (24%males,
9% females) ( p < 0.001); the highest prevalence was in those with
aortic stenosis ( p < 0.05). CAD was not seen in young patients
(aged <45 years) with none of the above-mentioned risk factors.
The highest correlation between CAD and risk factors was family
history of CAD, followed byDM, hyperlipidemia, hypertension, and
smoking in decreasing order.
Conclusion: The study results showed that CAD in patients with
valvular heart disease was less prevalent in our population.
The incidence of coronary lesions rises notably from the age of
50 years in both males and females. Coronary angiography
before valvular heart surgery could be omitted in young patients
(age <45 years) with none of the coronary risk factors, or without
angina.
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Background: Despite major advances in coronary hardware,
particularly the newer generation DES, in-stent restenosis
(ISR) following stent implantation is considered the Achilles'
heel in PCI treatment of CAD. We sought to study demographics
and clinical outcomes of stent restenosis following PCI from our
Institute.
Methods: Patients who underwent PCI between Jan 1 2001 and Dec
31, 2014 at SSSIHMS, Whiteﬁeld, Bangalore and returned with
symptoms suggesting ISR were evaluated as per demographic
parameters, functional status, comorbidities, and echocardio-
graphic parameters, including LVEF, angiographic, and angioplasty
details including type of stent and treatment offered. These were
collected at baseline, and at 9th month follow-up, and till last
known follow-up with us. When patient returned for a second
suspected ISR, they were similarly reevaluated. Angiographic ISR
was classiﬁed as perMehran classiﬁcation applied to both BMS and
DES.
Results: 14,634 patients underwent PCI in the above period, of
whom latest clinical and echocardiographic follow-up was avail-
able in 8317 patients (56.5%). Of these, 371 PCI patients (4.7%)
needed a second procedure for clinical and/or angiographic rest-
enosis (255 patients underwent PCI and 116 patients, CABG). Mean
age of patients was 56.3  9.1 years. Mean LVEF was 48.5  7/5%
during presentation. Among the 371 patients, 217 had a BMS
implanted initial PCI, 124 had DES implanted, and 30 had only
POBA as the initial PCI. The average stent dilation pressure was 14
 4 atm, post dilation was done in >90% of patients at an average
17 atm pressure. Among the 371 patients, average time from PCI to
ﬁrst readmission for restenosis was 334  34 days in CSA patients
(11–12 months) and for ACS patients, 227  18 days (7–9 months),
p < 0.01. CSA was the commonest presenting complaint with ISR
(n = 298) and 73 patients (19.5%) presented to us or elsewhere
with documented ACS (UA = 54, STEMI = 7, NSTEMI = 22). Among
the DES, the initial implanted stent was SES in 51, PES in 69, and
ZES in 4.
The earliest readmission for ISR causing a SAST was 91 days
(3 months, 1 day) in a diabetic patient. On propensity-based uni-
variate analysis, restenosis was more common in diabetics of >5
years duration irrespective of HbA1C status. Also, average stent
size was 2.5 mm vs larger diameter, and interestingly, when stent
size was >2.75 mm, stent length >24 mm became the strongest
predictive factor for future ISR. Male gender, PCI in bifurcation
lesions with two-stent strategy (any technique) vs single stent
strategy, and PCI in CTO lesions, PCI done in low EF (<35%) were
predisposing factors to development of ISR.
The type of ISR as per Mehran angiographic classiﬁcationwas focal
in 92, proliferative in 142, and total in 109 in the ﬁrst event of ISR.
BMS usagewas signiﬁcantly associated (>90% case) with type III/IV
proliferative ISR and more likely needed CABG in repeat admis-
sions while DES ISRwasmore likely to be focal (72% cases) andwas
treated with balloon angioplasty (POBA and scoring balloon in 51).
For the 371 ISR patients, repeat DES stentingwas done as SES = 144,
PES = 76, EES = 15, ZES Endeavour = 16. 18 underwent POBA alone
to ISR lesion, 80were treatedwith repeat BMS stentingwith cutting
balloon-plasty, and 4 patients were treated with DEB and BMS. For
second restenosis, of the 223 patients available till last follow-up,
91 underwent a third angioplasty (75 with DES-SES = 66, EES = 5,
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) s 1 7 – s 4 8S18
ZES = 4) and 154 patients were referred for CABG after
angiography due to higher grades of ISR (proliferative and total
in 165, p < 0.001). Interestingly in 31 cases of DES stenting, new
lesions formed alongside with DES ISR. The mean time to next ISR
was 9.5  3.5 months and was signiﬁcantly lesser ( p < 0.01) com-
pared to time to ﬁrst ISR irrespective of DES stent type for the
ﬁrst ISR.
Conclusions: ISR occurs signiﬁcantly earlier in stenting in ACS
situations than for SIHD. BMS usage was signiﬁcantly associated
with higher grades of proliferative ISR and more likely needed
CABG while DES ISR was more likely to be focal. CSA was the
commonest presenting complaint with ISR. Other predictors
were smaller stent size (2.5 mm) and longer stent length
>24 mm, male gender, complex PCI in bifurcation lesions with
two-stent strategy (any technique), PCI in CTO lesions, PCI done
in low EF (<35%). However, no relation of future ISR was seen
with the use of same or hetero-DES after the ﬁrst ISR episode
among DES usage.
Limitations:Only 57% of patient follow up datawas available. Also,
IVUS/OCT usage was not done for patients due to lack of avail-
ability.
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Coronary aneurysms are rare and only few case reports are noted
for giant coronary aneurysms. We recently had an asymptomatic
adult male patient with a giant coronary aneurysm.
A 62 years old male patient of no cardiac symptoms and no
coronary risk factors was presented. Underwent routine cardiac
evaluation prior to applying for health insurance. Echo
showed well deﬁned circumscribed shadow in the right atrium.
CT coronary angiogram showed multiple coronary aneurysms
and a giant one arising from proximal RCA measuring
5.22 cm  4.12 cm. After conventional coronary angiogram
he underwent aneurysm ligation and SVG graft to distal RCA
successfully.
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Introduction: We prospectively collected data of all patients with
ACS (both STEMI & NSTEMI) presenting to our Department of
Cardiology from June 2014 to May 2015. Patients with any systemic
infection, cancer, or any known chronic inﬂammatory diseases
were excluded. Patients were divided into three groups according
to NLR. The primary end point was all causemortality at the end of
1 month.
Results: Total 456 patients with ACS (both STEMI & NSTEMI)
were included in the study. The mortality in three groups
were 5, 9, and 13% respectively in low, medium, and high NLR
groups.
Baseline characteristics are shown in table.
Baseline
characteristics
Low Medium High p value
N = 152
NLR < 1.6
N = 152
NLR = 1.6–2.9
N = 152
NLR > 2.9
Age (mean) (%) 62 (32–78) 60 (35–82) 68 (24–86) 0.849
Male % 72.1 (108) 73.68 (112) 75.65 (115) 0.298
Hypertension (%) 43.42 (66) 46.05 (70) 48.68 (74) 0.268
Diabetes
Mellitus (%)
32.23 (49) 36.18 (55) 40.78 (62) 0.564
LVEF% 55 (30–70) 55 (25–70) 45 (25–60) 0.496
Neutrophil
(100/mm3)
4.5 (2.5–17.1) 5.6 (1.6–13.25) 6.9 (3.1–17) <0.001
Lymphocyte
(100/mm3)
3.2 (0.72–17) 2.5 (0.4–4.93) 1.42 (0.48–4.2) <0.001
NLR 1.4 (0.5–1.6) 2.41 (1.6–2.9) 4.1 (2.9–12.9) <0.001
All statistical analyses were performed using the SPSS pro-
gram. Quantitative variables were expressed as the median
(interquartile range), and qualitative variables were expressed
as percentages (%). Categorical variableswere compared by chi
square test. Themedian age of patients included in this cohort
was 64 years with males consisting of over 2/3 of patients.
Prevalence of patients having high NLR ratio increases as the
prevalence of diabetes mellitus and hypertension increases.
Patients with high NLR ratio have systolic dysfunction with
consequent poor prognosis & mortality.
Conclusion: Total and differential leukocyte count are basic and
inexpensive analyses in patients with ACS. NLR is an independent
predictor of high risk in patients with ACS, hence it should be used
in risk stratiﬁcation of patients with ACS.
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Introduction: Cardiovascular disease is the leading cause of death
among patients with chronic kidney disease (CKD). Recent studies
have conﬁrmed that even early CKD constitutes a signiﬁcant risk
factor for cardiovascular events and mortality. Many trials have
evaluated the prognostic value of renal impairment in acute cor-
onary syndrome (ACS) using serum creatinine level above the
normal limit as an indicator of renal impairment. From our current
knowledge we know that glomerular ﬁltration rate (GFR) is a better
index of renal function. There are numerous formulae and equa-
tions for estimating the GFR, the most precise one is the Chronic
Kidney Disease Epidemiology Collaboration (CKD-EPI formula).
Aims and objective: Our study was planned to determine the
relationship between GFR at the time of admission and the in-
hospital mortality in patients with ACS whose baseline creatinine
level was within normal limits and to evaluate inﬂuence of dia-
betes on the same.
Methods: This study included 59 patients with ACS admitted to the
CCU of Minia University Hospital in Egypt. Only ACS patients with
serum creatinine level of ≤1.3 mg/dl were included. For each
patients, age, sex, presence of cardiovascular risk factors such
as diabetes mellitus, smoking, HTN, dyslipidemia, family history
of premature CAD, and any background of IHD were collected.
Hemoglobin and baseline creatinine level TLC, RBG, troponin I
were determined at admission. Estimation of GFR using CKD-EPI
formula andMayo Clinic formulae were calculated. The Killip class
i n d i a n h e a r t j o u rn a l 6 7 ( 2 0 1 5 ) s 1 7 – s 4 8 S19
